The Bax/BCL2 ratio in the control group of B16F10 and LMM were both approximately 1.3, but the percentage in both cell lines increased over 1.5 when the 125 μg/mL CM was adopted; thus, CM could induce apoptosis in tumor cells. Here, BCL2 is linked to neoplasm.